It's Tuesday, May 27th.
I'm Jane Koston, and this is Why Today,
the show that hopes you enjoyed your holiday weekend and didn't spend any time online,
so you don't know about anything involving the wife of the president of France,
because life is just better that way.
On today's show, President Donald Trump threatens more tariffs, then backtracks.
Again!
And Russia unleashes another massive drone and missile strike on Ukraine.
But let's start with reproductive rights in America and the creative ways the Republican Party has sought to undermine them.
Health and Human Services Secretary Robert F. Kennedy Jr. asked the Food and Drug Administration earlier this month to review its decades-old approval of mifepristone,
a drug that can end early-stage pregnancies.
He did so in light of a report from the Ethics and Public Policy Center,
or EPPC, a conservative think tank that creatively entitled its report,
The Abortion Pill Harms Women.
The report argues that adverse events caused by mefapristone are 22 times more likely than the FDA currently recognizes.
Missouri Senator Josh Hawley asked RFK Jr. about the report in a Senate health hearing earlier this month.
Don't you think that this new data shows that the need to do a review is in fact very pressing?
And it's alarming, and clearly it indicates that at very least the label should be changed.
I've asked Marty McCary, who's the director of FDA, to do a complete review and to report back.
Good.